Shandong Cancer Hospital And Institute
Clinical trials sponsored by Shandong Cancer Hospital And Institute, explained in plain language.
-
Targeted radiation blast tested for tough pancreatic tumors
Disease control Not yet recruitingThis early-stage study is testing the safety of a new, highly focused radiation technique called SCART for people with locally advanced pancreatic cancer that cannot be surgically removed. The goal is to see if delivering a very high dose of radiation directly to the center of th…
Phase: PHASE1 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Apr 03, 2026 21:41 UTC
-
New combo attack on tough pancreatic cancer
Disease control Not yet recruitingThis study is testing whether combining a precise, high-dose radiation treatment with a specific chemotherapy regimen can better control locally advanced pancreatic cancer. It will involve 42 adults who have not had prior cancer treatment, comparing if giving the radiation early …
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists map the molecular landscape of aggressive breast cancer
Knowledge-focused Not yet recruitingThis study aims to learn more about the molecular characteristics of HER2-positive breast cancer. It will observe over 1,000 patients receiving standard pre-surgery drug treatment (trastuzumab, pertuzumab, and chemotherapy). The main goal is to identify different molecular subtyp…
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC